492 related articles for article (PubMed ID: 11675828)
1. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
Franzosi MG
Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
[No Abstract] [Full Text] [Related]
2. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
Pereira H;
Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
[No Abstract] [Full Text] [Related]
3. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of thrombolysis in acute myocardial infarction.
Gambhir DS
Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636
[No Abstract] [Full Text] [Related]
5. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
[TBL] [Abstract][Full Text] [Related]
6. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
Lincoff AM; Califf RM; Van de Werf F; Willerson JT; White HD; Armstrong PW; Guetta V; Gibler WB; Hochman JS; Bode C; Vahanian A; Steg PG; Ardissino D; Savonitto S; Bar F; Sadowski Z; Betriu A; Booth JE; Wolski K; Waller M; Topol EJ;
JAMA; 2002 Nov; 288(17):2130-5. PubMed ID: 12413372
[TBL] [Abstract][Full Text] [Related]
7. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S
Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
Patel VB; Moliterno DJ
J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
[No Abstract] [Full Text] [Related]
9. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
Gurm HS; Lincoff AM; Lee D; Tang WH; Jia G; Booth JE; Califf RM; Ohman EM; Van de Werf F; Armstrong PW; Guetta V; Wilcox R; Topol EJ;
J Am Coll Cardiol; 2004 Feb; 43(4):542-8. PubMed ID: 14975461
[TBL] [Abstract][Full Text] [Related]
10. [Thrombolytic therapy for acute myocardial infarct].
Nordt TK; Bode C
Internist (Berl); 2001 May; 42(5):659-64. PubMed ID: 11400573
[No Abstract] [Full Text] [Related]
11. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
Topol EJ;
Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition.
Califf RM
Am Heart J; 2000 Feb; 139(2 Pt 2):S33-7. PubMed ID: 10650314
[TBL] [Abstract][Full Text] [Related]
13. Multimodality reperfusion therapy for acute myocardial infarction.
Cannon CP
Am Heart J; 2000 Nov; 140(5):707-16. PubMed ID: 11054614
[TBL] [Abstract][Full Text] [Related]
14. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
[TBL] [Abstract][Full Text] [Related]
15. Overview of the use of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction.
Joseph A
J Emerg Med; 1999; 17(3):567-73. PubMed ID: 10338258
[No Abstract] [Full Text] [Related]
16. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Fernandez JS; Sadaniantz A
Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
[No Abstract] [Full Text] [Related]
17. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
Chew DP; Moliterno DJ; Herrmann HC
J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
[No Abstract] [Full Text] [Related]
18. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
Ferreira D
Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
[No Abstract] [Full Text] [Related]
19. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological reperfusion in acute myocardial infarct].
Lorenzoni R; Gensini GF; De Caterina R
G Ital Cardiol; 1998 Dec; 28(12):1441-55. PubMed ID: 9887401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
